🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07513740
Recruiting Not applicable

PENG vs Deep Iliacus Plane Block in Intertrochanteric Femur Fractures

NCT07513740 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-03-01
Last updated
2026-04-07

Condition(s) studied

Postoperative AnalgesiaHip Surgery

Investigational drug(s) / intervention(s)

Intravenous Analgesia →Pericapsular nerve group (PENG) blockDeep Iliacus Plane Block (DIPB)

Intravenous Analgesia: Standard preoperative intravenous analgesia according to institutional protocol.

Pericapsular nerve group (PENG) block: Ultrasound-guided PENG block with injection of 30 mL of 0.25% bupivacaine.

Deep Iliacus Plane Block (DIPB): Ultrasound-guided Deep Iliacus Plane Block with injection of 30 mL of 0.25% bupivacaine.

Study summary

Intertrochanteric femur fractures are common in elderly patients and are associated with significant pain. Providing effective analgesia is clinically important both during positioning for spinal anesthesia and in the postoperative period in this patient population.

The Pericapsular Nerve Group (PENG) block is a regional anesthesia technique that targets the articular branches of the hip capsule and may provide effective analgesia with motor-sparing potential. The Deep Iliacus Plane Block (DIPB) is a newer approach that may spread to both the articular branches and the lateral femoral cutaneous nerve.

Although both blocks are used in patients with intertrochanteric fractures, there is a lack of sufficient randomized controlled data comparing their effectiveness for pain during positioning for spinal anesthesia and for postoperative analgesia. Therefore, it is important to determine which technique provides greater clinical benefit.

The aim of this study is to compare the analgesic efficacy of the PENG block and the Deep Iliacus Plane Block during positioning for spinal anesthesia and in the postoperative period in patients undergoing surgery for intertrochanteric femur fractures.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Patients scheduled for elective surgery for intertrochanteric femur fractures * Patients with ASA physical status I, II, or III * Patients aged between 30 and 85 years Exclusion Criteria: * Patients with ASA physical status IV or higher * Patients undergoing emergency surgery * Patients who refuse to participate or withdraw consent during the study * Patients with cognitive dysfunction such as Alzheimer's disease, dementia, or delirium * Patients with a history of local anesthetic toxicity * Patients with infection at the planned block site * Patients with bleeding diathesis * Patients undergoing additional surgical procedures or additional anesthesia (e.g., general anesthesia) * Patients with a history of chronic opioid use or receiving treatment for neuropathic pain

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Erzincan Mengücek Gazi Eğitim ve Araştırma Hastanesi Erzincan Merkez/Türkiye Recruiting

More Erzincan Binali Yildirim Universitesi trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07513740 on ClinicalTrials.gov ↗ ← All trials in Turkey